Unknown Author
January 24, 2026
Latham Advises on Financing for Frazier Healthcare Partners’ Completed Acquisition of BioMatrix
1 min
AI-made summary
- Frazier Healthcare Partners, a Seattle-based investment firm focused on healthcare, has completed its acquisition of BioMatrix Holdings, LLC, a specialty infusion pharmacy
- Latham & Watkins LLP represented the private credit lenders involved in the transaction, with a team comprising partners and associates from New York, Chicago, Los Angeles, Houston, and Washington, D.C., providing legal advice on tax, healthcare regulatory, and employee benefits matters.
Frazier Healthcare Partners, a Seattle-based, healthcare-focused investment firm, has announced that it has completed its acquisition of BioMatrix Holdings, LLC, a leading specialty infusion pharmacy. Latham & Watkins LLP represented the private credit lenders in the transaction with a team led by New York partners Stelios Saffos and Peter Sluka, Chicago partner John Lister, Los Angeles partners Jason Bosworth and Jeff Senac, and Houston counsel Bryce Kaufman, with associate Sean Travers. Advice was also provided on tax matters by New York partner Bora Bozkurt, with associate Sam Yang; on healthcare regulatory matters by Washington, D.C. counsel Nicole Liffrig Molife; and on employee benefits matters by Chicago partner Ben Rosemergy.~~
Article Author
Unknown Author
The Sponsor
